The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer’s Disease
Background/Objectives: Mild behavioral impairment (MBI) is an early marker of Alzheimer’s disease (AD) and other neurodegenerative diseases, often preceding cognitive decline. The MBI Checklist (MBI-C) is a 34-item tool designed to detect MBI. This study aimed to assess the psychometric properties o...
Saved in:
| Main Authors: | Efthalia Angelopoulou, Evangelia Stanitsa, Maria Hatzopoulou, Akylina Despoti, Niki Tsinia, Vasiliki Kamtsadeli, Marina Papadogiani, Vasilis Kyriakidis, Sokratis Papageorgiou, John D. Papatriantafyllou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Brain Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/15/5/462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of the prevalence of Mild Behavioral Impairment subdomains in populations from cognitively normal to Mild Cognitive Impairment according to International Society for Advanced Alzheimer's Research and Treatment criteria
by: Virginia Quicchi
Published: (2023-08-01) -
Blood-based biomarkers in mild behavioral impairment: an updated overview
by: Efthalia Angelopoulou, et al.
Published: (2025-02-01) -
Validation of the Mild Behavioral Impairment Scale (MBI-S) for brief self-assessment of Mild Behavioral Impairment in people without dementia
by: Paula Hinkl, et al.
Published: (2025-05-01) -
Dynamic changes and prognostic value of glutathione S-transferase alpha in mild cognitive impairment and Alzheimer’s disease
by: Yangyang Tang, et al.
Published: (2024-12-01) -
A panel of altered blood oxysterols in patients with mild cognitive impairment: A novel combined diagnostic marker
by: Yu An, et al.
Published: (2025-03-01)